HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of a Treponema pallidum IgM immunoblot with a 19S fluorescent treponemal antibody absorption test for the diagnosis of congenital syphilis.

Abstract
We compared an in-house Treponema pallidum IgM immunoblot (IB) with a 19S fluorescent treponemal antibody absorption (IgM) test during routine use for the diagnosis of congenital syphilis (CS) in a national reference laboratory in a nonendemic setting. The overall agreement between the assays was high (97%), and 19S positive samples had at least 2 reactive bands in the IB. The high agreement is mainly caused by the large number of negative results (95%). If the 19S is taken as the gold standard, the estimate sensitivity of the IB was at least 88% with a specificity of 97.2%. Analysis of the discrepancies revealed that the IB was positive with 1 or 2 specific bands in 2.8% of the cases, whereas 19S was negative, possibly indicating higher sensitivity of the IB. We conclude that the IB is a sensitive method to detect contact with T. pallidum in neonates and can replace the 19S in routine laboratory screening for CS cases.
AuthorsMartina Herremans, Daan W Notermans, Mart Mommers, Laetitia M Kortbeek
JournalDiagnostic microbiology and infectious disease (Diagn Microbiol Infect Dis) Vol. 59 Issue 1 Pg. 61-6 (Sep 2007) ISSN: 0732-8893 [Print] United States
PMID17662551 (Publication Type: Comparative Study, Evaluation Study, Journal Article)
Chemical References
  • Immunoglobulin M
Topics
  • Female
  • Fluorescent Treponemal Antibody-Absorption Test
  • Humans
  • Immunoblotting (methods)
  • Immunoglobulin M (analysis)
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Pregnancy
  • Sensitivity and Specificity
  • Syphilis, Congenital (diagnosis, immunology)
  • Treponema pallidum (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: